Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
TransMedics Group Inc
TMDXCurrent price
82.4 USD
-0.36 USD (-0.43%)
Last closed
81.97 USD
Company
www.transmedics.com
ISIN
US89377M1099
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
4 169 950 976 USD
Yield for 12 month
+93.34 %
1Y
3Y
5Y
10Y
15Y
TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. Address: 200 Minuteman Road, Andover, MA, United States, 01810
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
183 USDP/E ratio
3129.25Dividend Yield
–Current Year
+241 623 000 USD
Last Year
+93 459 000 USD
Current Quarter
+114 305 000 USD
Last Quarter
+96 850 000 USD
Current Year
+153 993 000 USD
Last Year
+65 272 000 USD
Current Quarter
+69 161 000 USD
Last Quarter
+59 862 000 USD
Key Figures TMDX
1 year
3 years
5 years
10 years
EBITDA
42 808 000 USD
Operating Margin TTM
PE Ratio
3129.25
Return On Assets TTM
2.45 %
PEG Ratio
–
Return On Equity TTM
1.79 %
Wall Street Target Price
183 USD
Revenue TTM
358 759 008 USD
Book Value
5.7 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
117.9 %
Dividend Yield
–
Gross Profit TTM
65 272 000 USD
Earnings per share
0.04 USD
Diluted Eps TTM
0.04 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
0.84 %
Dividend Analytics TMDX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TMDX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation TMDX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
3129.25
Forward PE
90.9091
Enterprise Value Revenue
12.0518
Price Sales TTM
11.6233
Enterprise Value EBITDA
142.7196
Price Book MRQ
21.9593
Financials TMDX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TMDX
For 52 weeks
36.42 USD
177.37 USD
50 Day MA
148.44 USD
Shares Short Prior Month
6 016 782
200 Day MA
122.06 USD
Short Ratio
5
Shares Short
6 439 780
Short Percent
23.55 %
BeatStart